Kolexia
Paci Angelo Pharmacien
Paci Angelo
Pharmacien
Gustave-Roussy
Villejuif, France
168 Activités
5 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome corticosurrénalien Tumeurs du poumon Leucémie aigüe myéloïde Carcinome pulmonaire non à petites cellules Sarcomes Tumeurs corticosurrénaliennes Tumeurs du sein Tumeurs embryonnaires et germinales

Collaborateurs

Voir plus
Broutin Sophie
Broutin Sophie
Gustave-Roussy, Villejuif, France
Poinsignon Vianney
Poinsignon Vianney
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Mir Olivier
Mir Olivier
Amgen Sas, Neuilly-sur-Seine, France
Vassal Gilles
Vassal Gilles
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Pierre Fabre
8 collaboration(s)
Dernière en 2022
KEPHREN
4 collaboration(s)
Dernière en 2020
Pfizer
3 collaboration(s)
Dernière en 2022
MEDAC SAS
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review.
Journal of pain and symptom management   02 février 2024
36 Evaluation of transplacental transfer of cancer therapies in melanoma via the perfused human placental model
SMFM 44th Annual Meeting: The Pregnancy Meeting   01 janvier 2024
119 Transplacental transfer of alectinib and osimertinib using an ex vivo human placental perfusion model
SMFM 44th Annual Meeting: The Pregnancy Meeting   01 janvier 2024
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
Frontiers in immunology   18 octobre 2023
CANTO: A Cohort to Quantify and to Predict Treatment Related Chronic Toxicities in Patients With Non-metastatic Cancer - Breast and Lung.
Essai Clinique (Unicancer)   20 avril 2023
Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions.
Expert opinion on drug metabolism & toxicology   29 mars 2023
Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.
The Journal of clinical endocrinology and metabolism   29 septembre 2022
PemBOv trial: Pembrolizumab plus bevacizumab with or without pegylated liposomal doxorubicin-based chemotherapy in patients with platinum-resistant ovarian cancer.
2022 ASCO Annual Meeting I   02 juin 2022
VINILO: PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA
Essai Clinique (Gustave-Roussy)   24 mai 2022
Abstract P4-11-24: Patient's point of view on how to promote adherence to adjuvant endocrine therapy (ET): A large french survey
2021 San Antonio Breast Cancer Symposium   15 février 2022